Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06915103 · ClinicalTrials.gov registry record
A Case Report of NMDAR Encephalopathy
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 1
- Enrollment target
NCT06915103: Completed study, sponsored by Mayo Clinic.
NCT06915103 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06915103 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
This case illustrates the clinical, radiologic, and histopathologic features of Anti-NMDAR encephalitis and underscores the importance of MRI in detecting ovarian teratomas when pelvic ultrasound is inconclusive.
Primary Outcome
Diagnosis of Anti-NMDA Encephalitis based on pelvic MRI
Interventions
- DIAGNOSTIC_TEST Magnetic Resonance Imaging (MRI)
- PROCEDURE Salpingo-oophorectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2024-06-20 |
| Est. Completion | 2024-12-19 |
What the finished NCT06915103 record still lists
NCT06915103 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT06915103 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06915103 about?
NCT06915103 is a clinical study titled "A Case Report of NMDAR Encephalopathy". This case illustrates the clinical, radiologic, and histopathologic features of Anti-NMDAR encephalitis and underscores the importance of MRI in detecting ovarian teratomas when pelvic ultrasound is inconclusive.
What is the current status of trial NCT06915103?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2024-06-20. Estimated completion is 2024-12-19.
What interventions are being tested in trial NCT06915103?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (DIAGNOSTIC_TEST), Salpingo-oophorectomy (PROCEDURE).
Who is sponsoring clinical trial NCT06915103?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI